Evidence map›Paper›PMID 38528600›Full record

ArticleMolecular neurodegeneration2024

Correction: Unravelling cell type-specific responses to Parkinson's Disease at single cell resolution.

Araks Martirosyan, Rizwan Ansari, Francisco Pestana, Katja Hebestreit, Hayk Gasparyan, Razmik Aleksanyan, Silvia Hnatova, Suresh Poovathingal, Catherine Marneffe, Dietmar R Thal and 7 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular neurodegeneration, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Araks Martirosyan *VIB Center for Brain & Disease Research, KU Leuven, Leuven, Belgium.
Rizwan Ansari *Department of Clinical Neurosciences, UK Dementia Research Institute, University of Cambridge, CB2 0AH, Cambridge, UK.
Francisco Pestana *VIB Center for Brain & Disease Research, KU Leuven, Leuven, Belgium.
Katja HebestreitVerge Genomics, South San Francisco, CA, USA.
Hayk GasparyanArmenian Bioinformatics Institute, Yerevan, Armenia.
Razmik AleksanyanArmenian Bioinformatics Institute, Yerevan, Armenia.
Silvia HnatovaDepartment of Clinical Neurosciences, UK Dementia Research Institute, University of Cambridge, CB2 0AH, Cambridge, UK.
Suresh PoovathingalVIB Center for Brain & Disease Research, KU Leuven, Leuven, Belgium.
Catherine MarneffeVIB Center for Brain & Disease Research, KU Leuven, Leuven, Belgium.
Dietmar R ThalLaboratory for Neuropathology, Department of Imaging and Pathology, Leuven Brain Institute, Department of Pathology, KU Leuven, UZ Leuven, Leuven, Belgium.
Andrew KottickVerge Genomics, South San Francisco, CA, USA.
Victor J Hanson-SmithVerge Genomics, South San Francisco, CA, USA.
Sebastian GuelfiVerge Genomics, South San Francisco, CA, USA.
William PlumblyDepartment of Clinical Neurosciences, UK Dementia Research Institute, University of Cambridge, CB2 0AH, Cambridge, UK.
T Grant BelgardThe Bioinformatics CRO, Orlando, FL, USA.
Emmanouil MetzakopianDepartment of Clinical Neurosciences, UK Dementia Research Institute, University of Cambridge, CB2 0AH, Cambridge, UK. manos.metzakopian@bit.bio.ORCID http://orcid.org/0000-0003-2893-9741
Matthew G HoltVIB Center for Brain & Disease Research, KU Leuven, Leuven, Belgium. mholt@i3s.up.pt.ORCID http://orcid.org/0000-0002-8958-4027

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38528600
PMCPMC10964519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.